{"DataElement":{"publicId":"3005061","version":"1","preferredName":"Renal Neoplasm Histologic Grade Clinical Trials Eligibility Criteria Type","preferredDefinition":"the type or extent of the histologic grade of a renal neoplasm, used to determine whether an individual can participate in a specific clinical trial.","longName":"RENLNEO_HG_CTEC_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3004076","version":"1","preferredName":"Renal Neoplasm Histologic Grade Clinical Trials Eligibility Criteria","preferredDefinition":"information relating to clinical trial eligibility criteria (elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial) and the histologic grade (the degree of abnormality of cancer cells as a measure of differentiation) of a renal neoplasm (a malignant tissue growth resulting from uncontrolled cell proliferation in the kidney).","longName":"RENLNEO_HISTGD_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2638300","version":"1","preferredName":"Renal Neoplasm","preferredDefinition":"Of or pertaining to the kidney.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C25225:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"308665A0-5D6F-5397-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-15","modifiedBy":"ONEDATA","dateModified":"2007-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3004074","version":"1","preferredName":"Histologic Grade Clinical Trials Eligibility Criteria","preferredDefinition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C18000:CL008804","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trials Eligibility Criteria","conceptCode":"CL008804","definition":"Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E3F5C28-BF7A-ED12-E040-BB89AD4309DF","latestVersionIndicator":"Yes","beginDate":"2010-01-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-01-28","modifiedBy":"ONEDATA","dateModified":"2010-01-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E3F5C28-BF8B-ED12-E040-BB89AD4309DF","latestVersionIndicator":"Yes","beginDate":"2010-01-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-01-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3005055","version":"1","preferredName":"Renal Histologic Grade Eligibility Type","preferredDefinition":"the type or extent of the histologic grade of a renal neoplasm, used to determine whether an individual can participate in a specific clinical trial.","longName":"REN_HIST_GD_ELIG_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"G3 - 4","valueDescription":"G3 - 4","ValueMeaning":{"publicId":"3005056","version":"1","preferredName":"G3 - 4","longName":"3005056","preferredDefinition":"G3 - 4","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E8B820D-9331-941C-E040-BB89AD435B7F","latestVersionIndicator":"Yes","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E8B820D-934A-941C-E040-BB89AD435B7F","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"ONEDATA","dateModified":"2010-02-01","deletedIndicator":"No"},{"value":"G2","valueDescription":"G2","ValueMeaning":{"publicId":"3005057","version":"1","preferredName":"G2","longName":"3005057","preferredDefinition":"G2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E8B820D-9354-941C-E040-BB89AD435B7F","latestVersionIndicator":"Yes","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E8B820D-936D-941C-E040-BB89AD435B7F","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"ONEDATA","dateModified":"2010-02-01","deletedIndicator":"No"},{"value":"G1","valueDescription":"G1","ValueMeaning":{"publicId":"3005058","version":"1","preferredName":"G1","longName":"3005058","preferredDefinition":"G1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E8B820D-9377-941C-E040-BB89AD435B7F","latestVersionIndicator":"Yes","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E8B820D-9390-941C-E040-BB89AD435B7F","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"ONEDATA","dateModified":"2010-02-01","deletedIndicator":"No"},{"value":"GX","valueDescription":"GX","ValueMeaning":{"publicId":"3005059","version":"1","preferredName":"GX","longName":"3005059","preferredDefinition":"GX","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E8B820D-939A-941C-E040-BB89AD435B7F","latestVersionIndicator":"Yes","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E8B820D-93B3-941C-E040-BB89AD435B7F","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"ONEDATA","dateModified":"2010-02-01","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887210B1-455F-13BD-E040-BB89AD436340","beginDate":"2010-06-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"},{"value":"Fuhrman grade 3-4","valueDescription":"Fuhrman grade 3-4","ValueMeaning":{"publicId":"3107425","version":"1","preferredName":"Fuhrman grade 3-4","longName":"3107425","preferredDefinition":"Fuhrman grade 3-4","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"887210B1-4569-13BD-E040-BB89AD436340","latestVersionIndicator":"Yes","beginDate":"2010-06-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887210B1-4582-13BD-E040-BB89AD436340","beginDate":"2010-06-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"},{"value":"Fuhrman grade 1-2","valueDescription":"Fuhrman grade 1-2","ValueMeaning":{"publicId":"3107426","version":"1","preferredName":"Fuhrman grade 1-2","longName":"3107426","preferredDefinition":"Fuhrman grade 1-2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"887210B1-458C-13BD-E040-BB89AD436340","latestVersionIndicator":"Yes","beginDate":"2010-06-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887210B1-45A5-13BD-E040-BB89AD436340","beginDate":"2010-06-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"},{"value":"Not specified","valueDescription":"Not specified","ValueMeaning":{"publicId":"2567693","version":"1","preferredName":"Not specified","longName":"2567693","preferredDefinition":"Not stated explicitly or in detail.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D57A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D605E997-9519-8D0E-E040-BB89AD43757D","beginDate":"2013-02-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-18","modifiedBy":"ONEDATA","dateModified":"2013-02-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E8B820D-931D-941C-E040-BB89AD435B7F","latestVersionIndicator":"Yes","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"ZIEGLERK","dateModified":"2013-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"RENLNEO_HG_CTEC_TP","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Nuclear Grade","url":null,"context":"CTEP"},{"name":"Histologic grade","type":"Preferred Question Text","description":"Histologic grade","url":null,"context":"CTEP"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7E8B820D-93BD-941C-E040-BB89AD435B7F","latestVersionIndicator":"Yes","beginDate":"2010-02-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-01","modifiedBy":"FORMBUILDER","dateModified":"2014-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}